Marley Drug

Winston-salem, United States Founded: 2003 • Age: 23 yrs Acquired By Medicure
Supplier of pharmaceutical products

About Marley Drug

Marley Drug is a Healthcare company based in Winston-salem (United States) founded in 2003, and was acquired by Medicure in December 2020. Supplier of pharmaceutical products. Its chief executive, as recorded, is Dave Marley. Its website marleydrug.com draws about 79 thousand monthly visits. Marley Drug offers products and services including Generic Medications, Brand Medications, Bexagliflozin, Soaanz, and Pitavastatin. Its focus areas include Pharmaceutical Distributors and Generic Drugs. Its competitors include Pfizer, AmerisourceBergen and Renee; 2 of its 3 listed competitors have raised funding.

Company details

Marley Drug was founded in 2003 and is located in Winston-Salem, United States. Operations are centered on the pharmaceutical sector, where products are supplied to meet distribution needs. Ownership is shared by Elizabeth Marley and Dave Marley, with Dave Marley designated as CEO. Services encompass the provision of pharmaceutical goods across relevant markets, supported by established infrastructure in the region.

  • Headquarters Winston-salem, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Pharmacy
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website marleydrug.com
  • Social X Facebook Instagram
  • Acquired by Medicure (Dec 2020)
Key Metrics

Products & Services of Marley Drug

Marley Drug offers a comprehensive portfolio of products and services, including Generic Medications, Brand Medications, Bexagliflozin, Soaanz, and Pitavastatin.

Generic Medications
Pharmaceuticals

Affordable drugs for chronic conditions like hypertension and mental health

Brand Medications
Pharmaceuticals

Select brand-name drugs offered at reduced prices directly

Bexagliflozin
Diabetes Treatment

Tablet for diabetes management with cost-effective pricing options

Soaanz
Cardiovascular Care

Generic torsemide tablet for fluid retention treatment

Pitavastatin
Cholesterol Management

Tablet to lower cholesterol levels affordably

Investors in Marley Drug

Marley Drug has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Medicure.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Affordable therapeutics are developed and e-commerce pharmacy services are provided.
1997medicure.comWinnipeg, Canada
Premium access

Investor details for Marley Drug

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Marley Drug

2 people are tracked at Marley Drug (2 in leadership).

NameRoleGroup
Elizabeth Marley
OwnerLeadership
Dave Marley
CEO & OwnerLeadership
Premium access

Complete people profiles for Marley Drug

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Marley Drug

2 dated milestones of Marley Drug across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded Marley Drug is founded.
  2. Exit Acquired by Medicure.

Competitors of Marley Drug

Marley Drug has 3 listed competitors in our database, 2 of them funded. They include Pfizer, AmerisourceBergen and Renee.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
pfizer.com1849New York, United States$8M
Pharmaceutical products for treating multiple diseases are provided.
amerisourcebergen.com1985Chesterbrook, United States46,000
Pharmaceutical distribution and supply chain services are provided globally.
renee.com2021Los Angeles, United States$8.2M
Diversified drugs are distributed by Renee in the United States.
Premium access

Detailed competitors of Marley Drug

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Marley Drug

The website of Marley Drug (marleydrug.com) receives about 79K visits a month and ranks #469,818 among all websites worldwide, #868 in Pharmacy.

  • Monthly visits
    79K

    ▲ 10.7% vs previous month

  • Unique visitors
    39K

    per month

  • Global rank
    #469,818

    among all websites

  • Category rank
    #868

    Health · Pharmacy

Similar websites

Websites whose visitors overlap most with Marley Drug. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bigmountaindrugs.com
100%
#1,782,915View details
honeybeehealth.com
100%
49.8K#522,324View details
canadamedpharmacy.com
canadamedpharmacy.com
98%
#2,220,360–
meded101.com
meded101.com
91%
#749,677–
thecarepharmacy.com
thecarepharmacy.com
90%
#272,248–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Marley Drug

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

3 companies that operate in the same segment as Marley Drug (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United StatesUSD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United StatesUSD 61.16 B55,000
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Marley Drug

Premium access

Complete news archive for Marley Drug

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Marley Drug

Marley Drug was founded in 2003.

Marley Drug is headquartered in Winston-salem, United States. It is registered at Winston-salem, North Carolina, United States.

Dave Marley is the CEO of Marley Drug, as recorded in our data.

Marley Drug was founded in 2003 and is located in Winston-Salem, United States. Operations are centered on the pharmaceutical sector, where products are supplied to meet distribution needs. Ownership is shared by Elizabeth Marley and Dave Marley, with Dave Marley designated as CEO. Services encompass the provision of pharmaceutical goods across relevant markets, supported by established infrastructure in the region.

Marley Drug's top competitors include Pfizer, AmerisourceBergen and Renee.

Marley Drug offers Generic Medications, Brand Medications, Bexagliflozin, Soaanz, and Pitavastatin.

Marley Drug has 1 investor. Key investors include Medicure.

Yes. Marley Drug was acquired by Medicure in December 2020.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available